BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 7, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Dec. 7, 2012
View Archived Issues
Strategies to overcome drug resistance in mutation-dependent cancers
Read More
Varenicline as a potential treatment for methamphetamine dependence
Read More
New antibodies presented for P. falciparum infection
Read More
Merck & Co. patents novel SYK inhibitors for respiratory disorders
Read More
Development of a novel, simple to use, non-radiological neuropathy-detection technology
Read More
Joint grant awarded for prostate cancer drug research
Read More
Scientists at Rhizen Pharmaceuticals present new PI3K inhibitors
Read More
Photocure discloses initial results from phase IIb trial of Cevira
Read More
Synta Pharmaceuticals discloses new inhibitors of CRAC and cytokine production
Read More
Type I interferon receptor 1 MAb evaluated in patients with scleroderma
Read More
Omeros patents new anti-MASP-2 monoclonal antibodies
Read More
Constellation Pharmaceuticals presents novel BRD4 inhibitors
Read More
First-in-patient trial data updated for PF-03084014
Read More
Japanese group divulges new agents for Helicobacter pylori infections
Read More
Preliminary phase I data presented on MLN-0128 for advanced solid malignancies
Read More
Cerecor signs option with Johns Hopkins for DAAO inhibitor platform
Read More
IMI launches new drug development projects
Read More
Peregrine Pharmaceuticals advances Cotara into pivotal phase III trial
Read More
RXi Pharmaceuticals begins second phase I study of anti-scarring drug
Read More
Thomson Reuters announces newest intelligence solution for drug development
Read More
Vical licenses adjuvant to Cyvax for malaria vaccines
Read More
FDA approves La Jolla Pharmaceutical's IND for CKD drug
Read More
Japan Tobacco applies for approval of single-tablet anti-HIV regimen in Japan
Read More
CLAVELA study completes enrollment
Read More
Gentium to begin phase I development of defibrotide in Japan
Read More
Regulatory approvals received for new study of Vacc-4x
Read More
Protalix and Pfizer sign new agreement for clinical development of Elelyso
Read More